Key Market Indicators
Sales of beta blocking medicines in Hungary are set to reach $31 million by 2026. In 2021, sales were $35 million, representing a 1.8% decline year-on-year. Since 2008, the Hungarian market has grown by a modest 0.2% per year. Hungary ranked thirteenth in 2021, with Austria coming in first at $35 million. Italy, Canada, and Australia followed in second, third and fourth place, respectively.
